Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSIMERTINIB vs TOPIRAMATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSIMERTINIB vs TOPIRAMATE: Safety Overview

Metric OSIMERTINIB TOPIRAMATE
Total FAERS Reports 27,750 28,609
Deaths Reported 12,456 3,527
Death Rate 44.9% 12.3%
Hospitalizations 5,277 7,098
Average Patient Age 68.2 yrs 38.4 yrs
% Female Patients 66.0% 74.5%
FDA Approval Date Nov 13, 2015 Apr 15, 2009
Manufacturer AstraZeneca Pharmaceuticals LP Golden State Medical Supply, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription